<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01197131</url>
  </required_header>
  <id_info>
    <org_study_id>protocol 1.0/18/06/2010</org_study_id>
    <nct_id>NCT01197131</nct_id>
  </id_info>
  <brief_title>Urinary Steroid Metabolites in Autism</brief_title>
  <official_title>Investigation of Urinary Steroid Metabolites in Children With Autism Spectrum Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intersci Research Association, Austria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intersci Research Association, Austria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Deviation of hormone formation within nerve cells and nerve system provides autism spectrum&#xD;
      disorder and neurodevelopment retardation through interaction of steroids with&#xD;
      neurotransmitter-receptors, calcium-channel receptors and genomic interaction via nuclear&#xD;
      steroid receptors.&#xD;
&#xD;
      Urinary steroid metabolites will be compared between children with autism spectrum disorder&#xD;
      and healthy controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism spectrum disorder presents many alterations in amino acid metabolism and in&#xD;
      neurotransmitter systems (gamma amino acid system, glutamate-glutamine, nicotine-acid,&#xD;
      serotonin-system) . Also alteration in gene activation within nerve cells and lymphocyte&#xD;
      cultures encloses over 600 genes, affecting a wide field of enzymes , metabolic pathways and&#xD;
      hormone formation. Male hormones and their precursors are often increased and their influence&#xD;
      to nerve cell growth and spine formation is evident.&#xD;
&#xD;
      The diagnosis of autism spectrum disorder is made in accordance of criteria of the Diagnostic&#xD;
      and Statistical Manual of Mental Disorders IV (DSM-IV) of the American Psychiatric&#xD;
      Association by an experienced and specialised paediatrician or psychologist and /or by an&#xD;
      Autism Diagnostic Interview-Revised (ADI-R) or Autism Diagnostic Observation Schedule (ADOS)&#xD;
      .&#xD;
&#xD;
      Overnight urine with measurement of quantity and time will be collected and a little part of&#xD;
      the urinary samples will be frozen for storage till analysis. Age, weight and length of the&#xD;
      children at collection time will be ascertained.&#xD;
&#xD;
      Four stratified groups (autistic boys, girls, and healthy controls, boys and girls, each age&#xD;
      5-15) will be formed.&#xD;
&#xD;
      Urinary samples will further remain anonymous through an Identification-Number (ID).&#xD;
&#xD;
      Analysis of hormones and the most of the known metabolites excreted in urine will be&#xD;
      performed by a specialised laboratory using gas chromatography-mass spectrometry (GC/MS)&#xD;
      analysis (University Hospital Bern, Steroid Laboratory, Switzerland).&#xD;
&#xD;
      The statistical analysis, with age, gender, weight, diagnosis and hormone analysis results as&#xD;
      factors , consists in linear regression analysis to detect deviation in hormone formation and&#xD;
      metabolism.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>difference in hormone formation and androgen precursors</measure>
    <time_frame>3 years</time_frame>
    <description>Calculation of hormone formation by comparison of urinary steroid metabolites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>difference in hormone formation in gender and age</measure>
    <time_frame>3 years</time_frame>
    <description>Hormone formation depends on age and gender and will be calculated by comparison of urinary steroid metabolites</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">160</enrollment>
  <condition>Autism</condition>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>autistic boys</arm_group_label>
    <description>Boys with autism spectrum disorder, age 5-15 years, diagnosis meets DSM-IV criteria ascertained by ADI-R or ADOS schedule or specialised paediatrician</description>
  </arm_group>
  <arm_group>
    <arm_group_label>autistic girls</arm_group_label>
    <description>Girls with autism spectrum disorder, age 5-15 years, diagnosis meets DSM-IV criteria ascertained by ADI-R or ADOS schedule or specialised paediatrician.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control boys</arm_group_label>
    <description>Healthy boys, age 5-15 years, mental status assessed by &quot;Marburger Beurteilungsskala zum Asperger-Syndrome&quot; (MBAS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control girls</arm_group_label>
    <description>Healthy girls, age 5-15 years, mental status assessed by &quot;Marburger Beurteilungsskala zum Asperger Syndrome&quot; (MBAS).</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      noninvasive overnight urine (morning urine)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Children , age 5-15 years with autism and autism spectrum disorder resident in Austria&#xD;
        without other severe or psychiatric disorders.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Autism spectrum disorder&#xD;
&#xD;
          -  Age 5-15 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Epilepsia&#xD;
&#xD;
          -  Psychotropic medication&#xD;
&#xD;
          -  other severe illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johann Kurz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intersci Research Association, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intersci Research Association</name>
      <address>
        <city>Leibnitz</city>
        <state>Steiermark</state>
        <zip>8430</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, Scully MA, Soldin SJ, Luu T, Lee NH. Gene expression profiling of lymphoblasts from autistic and nonaffected sib pairs: altered pathways in neuronal development and steroid biosynthesis. PLoS One. 2009 Jun 3;4(6):e5775. doi: 10.1371/journal.pone.0005775.</citation>
    <PMID>19492049</PMID>
  </reference>
  <reference>
    <citation>Hu VW, Sarachana T, Kim KS, Nguyen A, Kulkarni S, Steinberg ME, Luu T, Lai Y, Lee NH. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. 2009 Apr;2(2):78-97. doi: 10.1002/aur.73.</citation>
    <PMID>19418574</PMID>
  </reference>
  <reference>
    <citation>Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology. 2001 Nov 13;57(9):1618-28.</citation>
    <PMID>11706102</PMID>
  </reference>
  <reference>
    <citation>Geier DA, Geier MR. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett. 2007 Oct;28(5):565-73.</citation>
    <PMID>17984958</PMID>
  </reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>September 8, 2010</study_first_submitted>
  <study_first_submitted_qc>September 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2010</study_first_posted>
  <last_update_submitted>February 15, 2019</last_update_submitted>
  <last_update_submitted_qc>February 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Intersci Research Association, Austria</investigator_affiliation>
    <investigator_full_name>Kurz Johann MD</investigator_full_name>
    <investigator_title>Medical Doctor,</investigator_title>
  </responsible_party>
  <keyword>autism</keyword>
  <keyword>autism spectrum disorder</keyword>
  <keyword>steroids</keyword>
  <keyword>steroid metabolites</keyword>
  <keyword>urinary steroid metabolites</keyword>
  <keyword>hormone formation</keyword>
  <keyword>androgen precursor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>August 5, 2019</submitted>
    <returned>September 16, 2019</returned>
    <submitted>November 5, 2019</submitted>
    <returned>November 22, 2019</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

